High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
Perm J. 2015 ;19(4):76-83. PMID: 26517439
Tido Von Schoen-Angerer
Viscum album extract (European mistletoe), containing immune-active compounds with dose-dependent cytotoxic activity, is being used as an adjuvant cancer treatment in Europe. Few studies have been done with high-dose, fever-inducing Viscum album treatment. The authors retrospectively analyzed the case notes of patients with resectable bladder cancer who underwent initiation of high-dose Viscum album treatment at their clinic between January 2006 to December 2012. High-dose Viscum album showed a possible beneficial effect in 5 of 8 patients. No tumor progression was observed. Treatment was generally well tolerated and no patient stopped treatment because of side effects.